Patents Assigned to Virovahl
  • Peptides for the detection of HTLV-1 infection
    Patent number: 5017687
    Abstract: Four peptides corresponding to regions of the glycoprotein encoded by the env gene of HTLV1 are provided. These peptides which are immunologically reactive with HTLV-1 specific antibodies are useful in assays for detection of HTLV-1 infection or exposure and in compositions to elicit the production of antibodies against HTLV-1 in animals and man.
    Type: Grant
    Filed: June 13, 1988
    Date of Patent: May 21, 1991
    Assignee: Virovahl, S.A.
    Inventors: Anders Vahlne, Bo Svennerholm, Lars Rymo, Stig Jeansson, Peter Horal
  • Synthetic peptide antigen for the detection of HIV-2 infection
    Patent number: 4812556
    Abstract: A synthetic peptide antigen corresponding to a region of the glycoprotein gp41 encoded by the env gene of HIV-2 is provided. The peptide which is immunologically reactive with HIV-2 specific antibodies is useful in assays for detection of HIV-2 infection or exposure and in compositions to elicit the production of antibodies against HIV-2 in animals including man.
    Type: Grant
    Filed: May 18, 1987
    Date of Patent: March 14, 1989
    Assignee: Virovahl
    Inventors: Anders Vahlne, Bo Svennerholm, Lars Rymo, Stig Jeansson, Peter Horal